خبر ممتاز وطيران للسهم
اغلاق امس
37.52 $
يتداول فى البري ماركت
40 $
انشالله ننال منه ربح طيب اليوم
للمتابعة وهذا نص الخبر
ANSI Advanced Neuro receives FDA approval (37.55 )
Co announces that it has received FDA approval to market and sell its first generation rechargeable spinal cord stimulation systems, the Genesis RC and Genesis RC Dual Neurostimulation Systems. Co is building inventory to support a limited market test of its Genesis RCs, to be followed by a broader launch. Simultaneously, the co is preparing to file for approval of smaller and even more powerful second-generation rechargeable IPGs.
اغلاق امس
37.52 $
يتداول فى البري ماركت
40 $
انشالله ننال منه ربح طيب اليوم
للمتابعة وهذا نص الخبر
ANSI Advanced Neuro receives FDA approval (37.55 )
Co announces that it has received FDA approval to market and sell its first generation rechargeable spinal cord stimulation systems, the Genesis RC and Genesis RC Dual Neurostimulation Systems. Co is building inventory to support a limited market test of its Genesis RCs, to be followed by a broader launch. Simultaneously, the co is preparing to file for approval of smaller and even more powerful second-generation rechargeable IPGs.